文献速递乳房整形与再造美容整形

浸润性乳腺癌保乳治疗后脂肪移植的匹配病例对照研究

Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

该匹配病例对照研究纳入322例保乳治疗后行脂肪移植重塑乳房的浸润性乳腺癌患者,并为每例匹配一名未行脂肪移植的相似患者。中位随访4.6年后,两组局部事件、腋窝淋巴结转移、远处转移及对侧乳腺癌发生率均无显著差异,提示脂肪移植在保乳治疗后似乎安全。

要点

  • 保乳治疗后脂肪移植与未移植者局部事件发生率无显著差异(14 vs 16,p=0.49)。
  • 腋窝淋巴结转移、远处转移及对侧乳腺癌发生率两组间亦无显著差异。
  • 证据等级为治疗性III级,支持脂肪移植在保乳治疗后应用的安全性。

核心结论

  • 脂肪移植在乳腺癌保乳治疗后似乎是安全的手术。

研究设计与样本

  • 匹配病例对照研究,纳入2006至2013年322例原发性浸润性乳腺癌保乳治疗后行脂肪移植的患者,每例匹配一名相似特征但未行脂肪移植的对照。

主要发现

  • 脂肪移植后平均随访4.6年(范围0.1至10.2年),局部事件发生率脂肪移植组14例 vs 对照组16例(p=0.49)。
  • 腋窝淋巴结转移脂肪移植组3例 vs 对照组6例(p=0.23)。
  • 远处转移脂肪移植组14例 vs 对照组15例(p=0.67)。
  • 对侧乳腺癌脂肪移植组4例 vs 对照组4例(p=0.51)。

临床怎么用

  • 对于保乳治疗后需乳房重塑的浸润性乳腺癌患者,脂肪移植未显示增加复发或转移风险,可作为安全选项考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fat grafting has been widely indicated for postmastectomy and postlumpectomy breast reconstruction. The literature emphasizes the clinical efficacy of fat grafting, but experimental studies raise important questions about the recurrence risk because of the stimulation of remaining cancer cells by progenitor or adult adipocytes. Because breast conservative treatment provides a higher risk of residual cancer cells in the breast tissue compared with mastectomy, the authors set up a matched case-control study of fat grafting versus no fat grafting after breast conservative treatment. METHODS: The authors collected data from 322 consecutive patients operated on for a primary invasive breast cancer who subsequently underwent fat grafting for breast reshaping from 2006 to 2013. All patients were free of recurrence before fat grafting. For each patient, the authors selected one patient with similar characteristics who did not undergo fat grafting. RESULTS: After a mean follow-up of 4.6 years (range, 0.1 to 10.2 years) after fat grafting, or a corresponding time for controls, the authors observed no difference in the incidence of local events (fat grafting, n = 14; controls, n = 16; p = 0.49), axillary nodes metastasis (fat grafting, n = 3; controls, n = 6; p = 0.23), distant metastases (fat grafting, n = 14; controls, n = 15; p = 0.67), or contralateral breast cancer (fat grafting, n = 4; controls, n = 4; p = 0.51). CONCLUSION: Fat grafting seems to be a safe procedure after breast conservative treatment for breast cancer patients. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Petit JY, Maisonneuve P, Rotmensz N, et al. Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study. Plast Reconstr Surg. 2017. PMID: 28538546. doi:10.1097/PRS.0000000000003339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。